2002
Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
Burroughs A, Groszmann R, Bosch J, Grace N, Garcia-Tsao G, Patch D, Garcia-Pagan J, Dagher L. Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point? Gut 2002, 50: 425. PMID: 11839726, PMCID: PMC1773121, DOI: 10.1136/gut.50.3.425.Peer-Reviewed Original ResearchConceptsHepatic venous pressure gradientChronic hepatitis CVenous pressure gradientHepatitis CAntiviral therapyEnd pointChronic hepatitis C.Major healthcare problemBest end pointHepatitis C.HVPG measurementTherapeutic benefitTherapeutic evaluationTherapyHealthcare problemPatientsPressure gradientResponse
1997
Viral RNA in duodenal bile of cirrhotic patients with chronic hepatitis C.
Kuan S, Garcia-Tsao G, Cartun R, Emanuel J, West A. Viral RNA in duodenal bile of cirrhotic patients with chronic hepatitis C. Archives Of Pathology & Laboratory Medicine 1997, 121: 847-52. PMID: 9278613.Peer-Reviewed Original ResearchConceptsHepatitis C virusCirrhotic patientsDuodenal bileChronic hepatitis C virusHepatitis C virus RNAHCV-negative controlsChronic hepatitis C.C virus RNAReverse transcriptase-polymerase chain reactionViral RNATranscriptase-polymerase chain reactionCross-reacting antigenSeropositive patientsHepatitis C.Seronegative controlsEndoscopic evaluationBreast milkC virusPolymerase chain reactionCirrhotic liverC100 proteinAntigen immunoreactivePatientsBileVirus RNA